Postoperative radiotherapy is dispensable for OSCC patients with micrometastases in lymph nodes
- 23 Downloads
Lymph node metastasis is a decisive factor for performing postoperative radiotherapy for oral squamous cell carcinoma (OSCC). However, whether OSCC patients with only micrometastasis need postoperative radiotherapy is unclear. In this study, OSCC patients (n = 311) with negative (n = 247), only micrometastasis (n = 44) and macrometastasis (n = 20) were detected and selected by HE staining. Micrometastasis was re-assessed using immunohistochemical staining of cytokeratin (CK) in HE-negative patients to find out the false negative cases. The results indicated that, among the negative lymph node cases (n = 247), the positive rate of CK was 4.94% (n = 12). Besides, the clinical features of the primary tumor in relation to the only micrometastatic status and the value of the postoperative radiotherapy on the only micrometastasis patients were evaluated. Patients with only micrometastasis had higher T stage and inferior worst pattern of invasion (WPOI) than patients without micrometastasis, but they had longer overall survival (OS), metastasis-free survival (MFS), and disease-free survival (DFS) than macrometastasis patients. However, the survival time of only micrometastasis patients with or without postoperative radiotherapy was comparable, even in patients with inferior WPOI. Radiotherapy, however, may only benefit patients with IV/V levels of micrometastasis. These data indicated that postoperative radiotherapy is dispensable for only micrometastasis OSCC patients.
KeywordsOral squamous cell carcinoma Micrometastasis Radiotherapy Prognosis Worst pattern of invasion
Compliance with ethical standards
This retrospective study included patients diagnosed with primary OSCC in the Department of Pathology, Nanjing Stomatology Hospital, from 2010 to 2013. The use of samples and retrieval of data were approved by the Research Ethics Committee of Nanjing Stomatology Hospital.
Conflict of interest
- 4.Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE, Pantel K (1997) Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 337(17):1188–1194. https://doi.org/10.1056/nejm199710233371702 CrossRefPubMedGoogle Scholar
- 6.Negm H, Mosleh M, Fathy H, Hareedy A, Elbattawy A (2013) Cytokeratin immunohistochemically detected nodal micrometastases in N0 laryngeal cancer: impact on the overall occult metastases. Eur Arch Otorhinolaryngol 270(3):1085–1092. https://doi.org/10.1007/s00405-012-2094-4 CrossRefPubMedGoogle Scholar
- 11.Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY (2005) Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29(2):167–178CrossRefPubMedGoogle Scholar
- 13.Velosa C, Shi Q, Stevens TM, Chiosea SI, Purgina B, Carroll W, Rosenthal E, Morlandt A, Loree T, Brandwein-Weber MS (2017) Worst pattern of invasion and occult cervical metastases for oral squamous carcinoma. Head Neck. https://doi.org/10.1002/hed.24754
- 23.Patel V, Martin D, Malhotra R, Marsh CA, Doci CL, Veenstra TD et al (2013) DSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarrays. Oral Oncol 49(2):93–101. https://doi.org/10.1016/j.oraloncology.2012.08.001 CrossRefPubMedGoogle Scholar
- 25.Nieuwenhuis EJ, Leemans CR, Kummer JA, Denkers F, Snow GB, Brakenhoff RH (2003) Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction. Lab Invest 83(8):1233–1240CrossRefPubMedGoogle Scholar
- 27.Min KW, Houck JR Jr (1998) Protocol for the examination of specimens removed from patients with carcinomas of the upper aerodigestive tract: carcinomas of the oral cavity including lip and tongue, nasal and paranasal sinuses, pharynx, larynx, salivary glands, hypopharynx, oropharynx, and nasopharynx. Cancer Committee, College of American Pathologists. Arch Pathol Lab Med 122(3):222–230PubMedGoogle Scholar
- 30.Liao CT, Lee LY, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Yen TC (2011) Outcome analysis of patients with oral cavity cancer and extracapsular spread in neck lymph nodes. Int J Radiat Oncol Biol Phys 81(4):930–937. https://doi.org/10.1016/j.ijrobp.2010.07.1988 CrossRefPubMedGoogle Scholar